Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Gehtraining und medikamentose therapie bei der peripheren arteriellen verschlusskrankheit: randomisierte, prospektive, placebo-kontrollierte doppelblindstudie (Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study) [German]
Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G
Deutsche Medizinische Wochenschrift 1987 May 29;112(22):873-878
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

It was demonstrated in a prospective, randomized and placebo-controlled double-blind study of two groups of 15 patients each with peripheral arterial occlusive disease in stage IIb of Fontaine that the combination of intravenous and oral administration of Pentoxifylline with walk training was superior to walk training alone. Comparison of the two groups revealed a significant increase in pain-free walking capacity, as well as reduction in plasma viscosity and platelet aggregation in the patients of the combination group. A significant reduction in platelet aggregation and rigidity occurred with time in this group only, while there was no significant difference between the groups with regard to these two parameters at the end of the treatment period.

Full text (sometimes free) may be available at these link(s):      help